Trying to learn how to translate from the human translation examples.
From professional translators, enterprises, web pages and freely available translation repositories.
entresto sacubitril / valsartan
entresto sacubitril/valsartan
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
the active substances are sacubitril and valsartan.
de aktive stoffer er sacubitril og valsartan.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
entresto 24 mg/26 mg tablets sacubitril/valsartan
entresto 24 mg/26 mg tabletter sacubitril/valsartan
Last Update: 2017-04-26
Usage Frequency: 3
Quality:
it dissociates into two active substances, sacubitril and valsartan.
det består af to aktive stoffer, sacubitril og valsartan.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
there are no data from the use of sacubitril in pregnant women.
der er ingen data vedrørende anvendelse af sacubitril hos gravide kvinder.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
sacubitril blocks the breakdown of natriuretic peptides produced in the body.
sacubitril blokerer nedbrydningen af natriuretiske peptider, der produceres i kroppen.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
in vitro data indicate that sacubitril inhibits oatp1b1 and oatp1b3 transporters.
in vitro data tyder på, at sacubitril hæmmer oatp1b1- og oatp1b3-transportører.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
entresto 24 mg/26 mg film-coated tablets sacubitril/valsartan
entresto 24 mg/26 mg filmovertrukne tabletter sacubitril/valsartan
Last Update: 2017-04-26
Usage Frequency: 3
Quality:
entresto is a heart medicine that contains the active substances sacubitril and valsartan.
entresto er et hjertelægemiddel, der indeholder de to aktive stoffer sacubitril og valsartan.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
no evidence of embryo-foetal toxicity or teratogenicity was observed in rats treated with sacubitril.
der er ikke set tegn på embryoføtal toksicitet eller teratogenicitet hos rotter behandlet med sacubitril.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
administration with food has no clinically significant impact on the systemic exposures of sacubitril, lbq657 and valsartan.
administration sammen med mad har ingen klinisk signifikant indflydelse på den systemiske optagelse af sacubitril, lbq657 og valsartan.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
however, a mild transient interference of sacubitril with the early phase of fracture healing in adults cannot be excluded.
det kan dog ikke udelukkes, at sacubitril har en let forbigående påvirkning i den tidlige helingsfase af frakturer hos voksne.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
sacubitril is readily converted to lbq657 by carboxylesterases 1b and 1c; lbq657 is not further metabolised to a significant extent.
sacubitril omdannes nemt til lbq657 af carboxylesterase 1b og 1c; lbq657 metaboliseres ikke yderligere i signifikant udstrækning.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
at steady state, sacubitril and valsartan do not accumulate significantly, while lbq657 accumulates 1.6-fold.
sacubitril og valsartan akkumuleres ikke signifikant under steady-state, mens lbq657 akkumuleres 1,6 gange.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
following twice daily dosing of entresto, steady-state levels of sacubitril, lbq657 and valsartan are reached in three days.
efter indgift 2 gange daglig nås steady-state niveauer af sacubitril, lbq657 og valsartan på 3 dage.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
the components of entresto, sacubitril and valsartan, were excreted in the milk of lactating rats (see section 5.3).
entrestos komponenter sacubitril og valsartan blev udskilt i mælk hos diegivende rotter (se pkt.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
each 24 mg/26 mg tablet contains 24.3 mg sacubitril and 25.7 mg valsartan (as sacubitril valsartan sodium salt complex).
hver 24 mg/26 mg tablet indeholder 24,3 mg sacubitril og 25,7 mg valsartan (som sacubitril-valsartan- natriumsaltkompleks).
Last Update: 2017-04-26
Usage Frequency: 6
Quality:
in juvenile rats treated with sacubitril (postnatal days 7 to 70), there was a reduction in age-related bone mass development and bone elongation.
hos unge rotter behandlet med sacubitril (dag 7 til 70 postnatalt), var der en nedsættelse i aldersrelateret udvikling af knoglemasse og knoglelængdevækst.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
in a thorough qtc clinical study in healthy male subjects, single doses of entresto 194 mg sacubitril/206 mg valsartan and 583 mg sacubitril/617 mg valsartan had no effect on cardiac repolarisation.
i et omhyggeligt qtc-studie hos raske, frivillige mænd havde enkeltdoser på entresto 194 mg sacubitril/206 mg valsartan og 583 mg sacubitril/617 mg valsartan ingen virkning på hjertets repolarisation.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
since cyp450-enzyme-mediated metabolism of sacubitril and valsartan is minimal, co-administration with medicinal products that impact cyp450 enzymes is not expected to impact the pharmacokinetics.
da cyp-enzymmedieret metabolisering af sacubitril og valsartan er minimal, forventes administration sammen med cyp-enzymer ikke at influere på farmakokinetikken.
Last Update: 2017-04-26
Usage Frequency: 1
Quality: